Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CUR

Neuralstem (CUR) Stock Price, News & Analysis

Neuralstem logo

About Neuralstem Stock (NASDAQ:CUR)

Advanced Chart

Key Stats

Today's Range
$0.66
$0.69
50-Day Range
$0.67
$1.52
52-Week Range
$1.10
$13.78
Volume
81,273 shs
Average Volume
236,278 shs
Market Capitalization
$1.42 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CUR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Neuralstem and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CUR Stock News Headlines

Aguas Da Curia Share Price (CUR.LS)
XAUUSD:CUR Gold Spot Price
REVEALED FREE: Our top 3 stocks to own in 2025 and beyond
Every time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (including the losers!).tc pixel
4 Biotech Stocks Under $10 Moving Higher
XPTUSD:CUR Platinum Spot Price
XAUUSD:CUR
See More Headlines

CUR Stock Analysis - Frequently Asked Questions

Neuralstem, Inc. (NASDAQ:CUR) posted its earnings results on Wednesday, August, 14th. The company reported ($1.45) EPS for the quarter. The company had revenue of $0.01 million for the quarter. Neuralstem had a negative net margin of 39,417.64% and a negative trailing twelve-month return on equity of 170.51%.

Shares of Neuralstem reverse split on the morning of Thursday, July 18th 2019.The 1-20 reverse split was announced on Tuesday, July 16th 2019. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, July 17th 2019. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Neuralstem investors own include XOMA Royalty (XOMA), MannKind (MNKD), Cytokinetics (CYTK), Turkcell Iletisim Hizmetleri AS (TKC), Idera Pharmaceuticals (IDRA), SELLAS Life Sciences Group (SLS) and ACADIA Pharmaceuticals (ACAD).

Company Calendar

Last Earnings
8/14/2019
Today
8/29/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological Products, Except Diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:CUR
CIK
1357459
Fax
N/A
Employees
6
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$4.93 million
Net Margins
-39,417.64%
Pretax Margin
N/A
Return on Equity
-170.51%
Return on Assets
-110.16%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.53
Quick Ratio
2.53

Sales & Book Value

Annual Sales
$260 thousand
Price / Sales
5.49
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$6.64 per share
Price / Book
0.10

Miscellaneous

Outstanding Shares
2,100,000
Free Float
N/A
Market Cap
$1.43 million
Optionable
Not Optionable
Beta
1.81
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:CUR) was last updated on 8/30/2025 by MarketBeat.com Staff
From Our Partners